DC Migration Study for Newly-Diagnosed GBM

NCT02366728 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Astrocytoma, Grade IV
Giant Cell Glioblastoma
Glioblastoma Multiforme

Interventions

BIOLOGICAL: Unpulsed DCs
BIOLOGICAL: Td
BIOLOGICAL: Human CMV pp65-LAMP mRNA-pulsed autologous DCs
BIOLOGICAL: 111In-labeled DCs
DRUG: Temozolomide
DRUG: Saline
DRUG: Basiliximab

Sponsor

Mustafa Khasraw, MBChB, MD, FRCP, FRACP